Original Research

Published on 20 Aug 2024

Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study

in Vaccines and Molecular Therapeutics

Fatemeh Khosravi Shadmani
Ghobad Moradi
Mohammadreza Naghipour
Fatemeh Torkaman Asadi
Ali Ahmadi
Alireza Mirahmadizadeh
Ali Akbar Haghdoost
Bita Mesgarpour
Seyed Mohsen Zahraei
Mohammad Mehdi Goya

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420651

1,056 views

Original Research

Published on 16 Aug 2024

Expression of IL-1β in transgenic Eimeria necatrix enhances the immunogenicity of parasites and promotes mucosal immunity against coccidiosis

in Vaccines and Molecular Therapeutics

Chunhui Duan
Tumalisi Abudureheman
Si Wang
Jingxia Suo
Ying Yu
Fangyun Shi
Xianyong Liu
Dina B. Salama
Ratnesh Kumar Srivastav
Nishith Gupta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435702

1,045 views

Original Research

Published on 14 Aug 2024

Optimizing sheep B-cell epitopes in Echinococcus granulosus recombinant antigen P29 for vaccine development

in Vaccines and Molecular Therapeutics

Jihui Yang
Yongxue Lv
Yazhou Zhu
Jiahui Song
Mingxing Zhu
Changyou Wu
Yong Fu
Wei Zhao
Yinqi Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451538

723 views

Review

Published on 14 Aug 2024

Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines

in Vaccines and Molecular Therapeutics

Wan-Ying Zhang
Xiao-Li Zheng
Paolo Saul Coghi
Jun-Hui Chen
Bing-Jun Dong
Xing-Xing Fan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1438030

1,814 views

Editorial

Published on 14 Aug 2024

Editorial: Novel adjuvant systems that generate pathogen specific T cell responses following immunization for infectious disease vaccine formulations

in Vaccines and Molecular Therapeutics

Amanda M. Burkhardt
Szu-Wen Wang
Ali M. Harandi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467461

822 views

Brief Research Report

Published on 13 Aug 2024

A single domain antibody-based Luminex assay for the detection of SARS-CoV-2 in clinical samples

in Vaccines and Molecular Therapeutics

Ellen R. Goldman
Victor A. Sugiharto
Lisa C. Shriver-Lake
Andrew M. Garcia
Shuenn-Jue Wu
Sarah A. Jenkins
Hua-Wei Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446095

732 views

Original Research

Published on 12 Aug 2024

A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

in Vaccines and Molecular Therapeutics

Beibei Wu
Ye Liu
Xuexue Zhang
Ding Luo
Xuejie Wang
Chen Qiao
Jian Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420216

2,042 views

Original Research

Published on 08 Aug 2024

In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics

in Vaccines and Molecular Therapeutics

Simona Saporiti
Davide Bianchi
Omar Ben Mariem
Mara Rossi
Uliano Guerrini
Ivano Eberini
Fabio Centola

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429600

1,877 views

Brief Research Report

Published on 07 Aug 2024

Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques

in Vaccines and Molecular Therapeutics

Benjamin N. Bimber
Justine Sunshine
G. W. McElfresh
Jason S. Reed
Reese Pathak
Katherine B. Bateman
Colette M. Hughes
Roxanne M. Gilbride
Julia C. Ford
David Morrow

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444621

992 views

Original Research

Published on 05 Aug 2024

The relationship between influenza vaccine hesitancy and vaccine literacy among youth and adults in China

in Vaccines and Molecular Therapeutics

Li Wang
Mengjie Guo
Yan Wang
Ren Chen
Xiaolin Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444393

989 views
2 citations

Brief Research Report

Published on 02 Aug 2024

High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome

in Vaccines and Molecular Therapeutics

Friederike A. Arlt
Ameli Breuer
Elli Trampenau
Fabian Boesl
Marieluise Kirchner
Philipp Mertins
Elisa Sánchez-Sendín
Mahoor Nasouti
Marie Mayrhofer
Martin Blüthner

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404800

6,139 views
1 citation

Clinical Trial

Published on 29 Jul 2024

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

in Vaccines and Molecular Therapeutics

Mostafa Ghanei
Babak Ghalebaghi
Ramin Sami
Mehdi Torabizadeh
Majid Mirsadraee
Babak Amra
Marzieh Tavakol
Hanieh Raji
Morteza Fallahpour
Arda Kiani

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425906

2,788 views

Case Report

Published on 29 Jul 2024

Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult

in Vaccines and Molecular Therapeutics

Qiang Wang
Lin Lin
Junhui Zhen
Bei Jiang
Guangyi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1407461

1,175 views
1 citation

Original Research

Published on 26 Jul 2024

4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients

in Vaccines and Molecular Therapeutics

Maria Jose Gallardo-Nelson
Marcos Cruces
Yolanda M. Gómez
Constanza Fuenzalida
Javiera Silva
Laura Aravena-Traipi
Eduardo Nuñez
Aracelly Gaete-Angel
Elizabeth Rivas-Yañez
Alexis M. Kalergis

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427501

1,321 views

Original Research

Published on 26 Jul 2024

Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2

in Vaccines and Molecular Therapeutics

Juan Liu
Huafeng Han
Binbin Yang
Naifang Zhang
Jing Li
Xicheng Chen
Jie Wu
Yingying Zhao
Yongsheng Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1416375

1,443 views

Correction

Published on 25 Jul 2024

Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

in Vaccines and Molecular Therapeutics

Raymund R. Razonable

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440571

516 views
1 citation

Navigation group

Articles

Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study

Expression of IL-1β in transgenic Eimeria necatrix enhances the immunogenicity of parasites and promotes mucosal immunity against coccidiosis

Optimizing sheep B-cell epitopes in Echinococcus granulosus recombinant antigen P29 for vaccine development

Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines

Editorial: Novel adjuvant systems that generate pathogen specific T cell responses following immunization for infectious disease vaccine formulations

A single domain antibody-based Luminex assay for the detection of SARS-CoV-2 in clinical samples

A bibliometric insight into nanomaterials in vaccine: trends, collaborations, and future avenues

In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics

Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques

The relationship between influenza vaccine hesitancy and vaccine literacy among youth and adults in China

High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial

Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult

4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients

Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2

Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity